Mitigation of an anthracycline-induced cardiomyopathy by pretreatment with razoxane: a quantitative morphological assessment

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Virchows Archiv B Cell Pathology Including Molecular Pathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02899044PMID 2875560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early and late sarcoplasmic reticulum changes in doxorubicin cardiomyopathy

  1985cited by this paper
• The Pathomorphology of Daunorubicin-injured and ICRF-159 (Razoxane)-protected Murine Myocardium: Progress Report

  1984cited by this paper
• Influence of vitamin E and ICRF-187 on chronic doxorubicin cardiotoxicity in miniature swine.

  1983cited by this paper
• Early changes in human myocardial nuclei after doxorubicin

  1983cited by this paper
• Influence of vitamin E and ICRF-187 on chronic doxorubicin cardiotoxicity in miniature swine.

  1983cited by this paper
• Anthracycline cardiotoxicity.

  1983cited by this paper
• Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy.

  1983cited by this paper
• Mitigating effects of ICRF-159 (razoxane) on a daunomycin-induced cardiomyopathy in mice.

  1982cited by this paper
• Metal binding by pharmaceuticals. part 2. interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192

  1982cited by this paper
• Mitigating Effects of ICKF-159 (Kazoxane) on a Daunomycin-Induced Cardzomyopathy in Mice

  1982cited by this paper
• The anthracycline antineoplastic drugs.

  1981cited by this paper
• The role of doxorubicin-iron complex in superoxide production and membrane damage

  1981cited by this paper
• Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187).

  1981cited by this paper
• Reduction of daunomycin toxicity by razoxane.

  1981cited by this paper
• Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.

  1981cited by this paper
• Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration.

  1981cited by this paper
• Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits.

  1981cited by this paper
• Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters.

  1979cited by this paper
• Adriamycin: amelioration of toxicity by alpha-tocopherol.

  1976cited by this paper
• Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943).

  1974cited by this paper
• Prevention of the Cardiotoxic Effects of Adriamycin and Daunomycin in the Isolated Dog Heart 1

  1972cited by this paper
• Antitumour Activity in a Series of bisDiketopiperazines

  1969cited by this paper

• Doxorubicin Induces Sarcoplasmic Reticulum Calcium Regulation Dysfunction via the Decrease of SERCA2 and Phospholamban Expressions in Rats

  2014cites this paper
• An Experimental Study on the Sarcoplasmic Reticulum Calcium Handling in Myocardium Intoxicated by Doxorubicin

  2012cites this paper
• Pharmacologic Prevention of Anthracycline-Induced Cardiomyopathy

  2009cites this paper
• Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models

  2008cites this paper
• Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines.

  1998cites this paper
• Mechanisms for anthracycline-induced cardiomyopathy: clinical and laboratory correlations

  1997cites this paper
• Iron(II) is a modulator of ryanodine-sensitive calcium channels of cardiac muscle sarcoplasmic reticulum.

  1995cites this paper
• Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.

  1993cites this paper
• The effects of ICRF-154 in combination with other anticancer agents in vitro.

  1992cites this paper
• Therapeutic efficacy of two different cytostatic-linked phosphonates in combination with razoxane in the transplantable osteosarcoma of the rat

  1990cites this paper